J
Julie R. Hunt
Researcher at Fred Hutchinson Cancer Research Center
Publications - 42
Citations - 5790
Julie R. Hunt is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Women's Health Initiative & Randomized controlled trial. The author has an hindex of 26, co-authored 42 publications receiving 5294 citations.
Papers
More filters
Journal ArticleDOI
Design of the Women's Health Initiative clinical trial and observational study
Garnet L. Anderson,S. Cummings,L. S. Freedman,C. Furberg,Maureen M. Henderson,Susan R. Johnson,L. Kuller,JoAnn E. Manson,A. Oberman,Ross L. Prentice,Jacques E. Rossouw,L. Finnegan,R. Hiatt,L. Pottern,J. McGowan,C. Clifford,B. Caan,V. Kipnis,B. Ettinger,S. Sidney,G. Bailey,Andrea Z. LaCroix,Anne McTiernan,Deborah J. Bowen,C. Chen,Barbara B. Cochrane,Julie R. Hunt,Alan R. Kristal,Brian J. Lund,Ruth E. Patterson,Jeffrey L. Probstfield,Lesley F. Tinker,Nicole Urban,Ching Yun Wang,Emily White,J. M. Kotchen,S. Shumaker,P. Rautaharju,F. Rautaharju,E. Stein,P. Laskarzewski,P. Steiner,K. Sagar,M. Nevitt,M. Dockrell,T. Fuerst,John H. Himes,M. Stevens,F. Cammarata,S. Lindenfelser,Bruce M. Psaty,D. Siscovick,W. Longstreth,S. Heckbert,S. Wassertheil-Smoller,W. Frishman,Judy Wylie-Rosett,D. Barad,R. Freeman,S. Miller,Jennifer Hays,R. Young,C. Crowley,M. A. DePoe,G. Burke,E. Paskett,L. Wagenknecht,R. Crouse,L. Parsons,T. Kotchen,E. Braunwald,J. Buring,C. Hennekens,J. M. Gaziano,Annlouise R. Assaf,R. C. Carleton,M. Miller,C. Wheeler,A. Hume,M. Pedersen,O. Strickland,M. Huber,V. Porter,Shirley A.A. Beresford,V. Taylor,N. Woods,J. Hsia,V. Barnabei,M. Bovun,Rowan T. Chlebowski,R. Detrano,A. Nelson,J. Heiner,S. Pushkin,B. Valanis,V. Stevens,E. Whitlock,N. Karanja,A. Clark +98 more
TL;DR: The rationale for the interventions being studied in each of the CT components and for the inclusion of the OS component is described, including a brief description of the scientific and logistic complexity of the WHI.
Journal ArticleDOI
The women's health initiative recruitment methods and results
Jennifer Hays,Julie R. Hunt,F. Allan Hubbell,Garnet L. Anderson,Marian C. Limacher,Catherine Allen,Jacques E. Rossouw +6 more
TL;DR: One of the most challenging aspects of the Women’s Health Initiative (WHI) was the recruitment of more than 161,000 women for this long-term prevention trial and observational study.
Journal ArticleDOI
Estrogen therapy and coronary-artery calcification.
JoAnn E. Manson,Matthew A. Allison,Jacques E. Rossouw,J. Jeffrey Carr,Robert Langer,Judith Hsia,Lewis H. Kuller,Barbara B. Cochrane,Julie R. Hunt,Shari E. Ludlam,Mary Pettinger,Margery Gass,Karen L. Margolis,Lauren Nathan,Judith K. Ockene,Ross L. Prentice,John A Robbins,Marcia L. Stefanick +17 more
TL;DR: The calcified-plaque burden in the coronary arteries after trial completion was lower in women assigned to estrogen than in those assigned to placebo, however, estrogen has complex biologic effects and may influence the risk of cardiovascular events and other outcomes through multiple pathways.
Journal ArticleDOI
Retaining and Tracking Cohort Study Members
Julie R. Hunt,Emily White +1 more
TL;DR: Approaches for maximizing retention and minimizing loss to follow-up are reviewed, including the importance of communicating the expectations of participation and collecting personal information at baseline, conducting frequent personal and mail contact, and providing incentives for participation.
Journal ArticleDOI
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Hadine Joffe,Katherine A. Guthrie,Andrea Z. LaCroix,Susan D. Reed,Kristine E. Ensrud,Kristine E. Ensrud,JoAnn E. Manson,Katherine M. Newton,Ellen W. Freeman,Garnet L. Anderson,Joseph C. Larson,Julie R. Hunt,Jan L. Shifren,Kathryn M. Rexrode,Bette J. Caan,Barbara Sternfeld,Janet S. Carpenter,Lee S. Cohen +17 more
TL;DR: In this article, the mean VMS frequency at week 8 decreased to 3.9 (95% CI, 2.9-4.9) VMS per day (52.9% reduction) in the estradiol group, and to 5.5 (95 % CI, 4.7-6.3)